Nancy Van Osselaer

1.1k total citations
30 papers, 936 citations indexed

About

Nancy Van Osselaer is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Pharmacology. According to data from OpenAlex, Nancy Van Osselaer has authored 30 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 6 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Nancy Van Osselaer's work include Cell Adhesion Molecules Research (6 papers), Chemical synthesis and alkaloids (6 papers) and Alkaloids: synthesis and pharmacology (4 papers). Nancy Van Osselaer is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Chemical synthesis and alkaloids (6 papers) and Alkaloids: synthesis and pharmacology (4 papers). Nancy Van Osselaer collaborates with scholars based in Belgium, United States and Germany. Nancy Van Osselaer's co-authors include Jo Van Damme, M Rampart, Achiel Van Peer, Jan Hendrickx, Arnold G. Herman, Geert Mannens, Anja Wuyts, Sandra Boom, Bart Remmerie and Jean Willems and has published in prestigious journals such as Biochemistry, Free Radical Biology and Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Nancy Van Osselaer

29 papers receiving 895 citations

Peers

Countries citing papers authored by Nancy Van Osselaer

Since Specialization

Citations

This map shows the geographic impact of Nancy Van Osselaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Van Osselaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Van Osselaer more than expected).

Fields of papers citing papers by Nancy Van Osselaer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Van Osselaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Van Osselaer. The network helps show where Nancy Van Osselaer may publish in the future.

Co-authorship network of co-authors of Nancy Van Osselaer

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Van Osselaer. A scholar is included among the top collaborators of Nancy Van Osselaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Van Osselaer. Nancy Van Osselaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN) 2019 ·Journal of Cystic Fibrosis ·Silke van Koningsbruggen‐Rietschel, Katja Conrath, Rainald Fischer, Sivagurunathan Sutharsan, (unknown), Wolfgang Gleiber, C. Schwarz, Andreas Hector, Nancy Van Osselaer, Arian Pano, Sam Corveleyn, (unknown), Eva Santermans, (unknown), (unknown), (unknown)	10
2	Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2–positive allosteric modulator JNJ‐46356479 and levetiracetam in the mouse 6‐Hz (44‐mA) model 2018 ·Epilepsia ·Cameron S. Metcalf, Brian D. Klein, Misty D. Smith, Marc Ceusters, Hilde Lavreysen, Stefan Pype, Nancy Van Osselaer, Roy E. Twyman, H. Steve White	20
3	A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs 2017 ·Epilepsy & Behavior ·(unknown), M. Charokopou, Nancy Van Osselaer, Mickaël Hiligsmann	12
4	A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophrenia 2012 ·European Neuropsychopharmacology ·Mark E. Schmidt, Justine Kent, Ella Daly, Luc Janssens, Nancy Van Osselaer, (unknown), Ion‐George Anghelescu, Luc Van Nueten	26
5	Single‐ and Multiple‐Dose Pharmacokinetics and Dose Proportionality of the Psychotropic Agent Paliperidone Extended Release 2009 ·The Journal of Clinical Pharmacology ·Sandra Boom, Krishna Talluri, Luc Janssens, Bart Remmerie, Marc De Meulder, Stefaan Rossenu, Nancy Van Osselaer, Mariëlle Eerdekens, Adriaan Cleton	32
6	Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans 2008 ·Drug Metabolism and Disposition ·Marc Vermeir, (unknown), Bart Remmerie, Geert Mannens, Jan Hendrickx, Patrick Sterkens, Krishna Talluri, Sandra Boom, Mariëlle Eerdekens, Nancy Van Osselaer, Adriaan Cleton	133
7	Assays for Chemotaxis 2003 ·Humana Press eBooks ·Anja Wuyts, Patricia Menten, Nancy Van Osselaer, Jo Van Damme	9
8	Galantamine Population Pharmacokinetics in Patients with Alzheimer's Disease: Modeling and Simulations 2003 ·The Journal of Clinical Pharmacology ·Vladimir Piotrovsky, Achiel Van Peer, Nancy Van Osselaer, Martin Armstrong, Jeroen Aerssens	27
9	Galantamine Pharmacokinetics, Safety, and Tolerability Profiles Are Similar in Healthy Caucasian and Japanese Subjects 2002 ·The Journal of Clinical Pharmacology ·Qinying Zhao, Martin Brett, Nancy Van Osselaer, (unknown), (unknown), Achiel Van Peer, Tom Verhaeghe, (unknown)	9
10	Galantamine Pharmacokinetics, Safety, and Tolerability Profiles Are Similar in Healthy Caucasian and Japanese Subjects 2002 ·The Journal of Clinical Pharmacology ·Qinying Zhao, (unknown), Nancy Van Osselaer, Fenglei Huang, (unknown), Achiel Van Peer, Tom Verhaeghe, (unknown)	27
11	The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans 2002 ·Drug Metabolism and Disposition ·Geert Mannens, (unknown), Jan Hendrickx, Tom Verhaeghe, L. Le Jeune, (unknown), Ludy van Beijsterveldt, Karel Lavrijsen, J. Leempoels, Nancy Van Osselaer, A. Van Peer, W. Meuldermans	81
12	Evidence that inducible nitric oxide synthase is involved in LPS‐induced plasma leakage in rat skin through the activation of nuclear factor‐κB 1998 ·British Journal of Pharmacology ·Teresa Iuvone, Fulvio D’Acquisto, Nancy Van Osselaer, Massimo Di Rosa, Rosa Carnuccio, Arnold G. Herman	39
13	Localization of Extracellular Superoxide Dismutase in Rat Lung: Neutrophils and Macrophages as Carriers of the Enzyme 1998 ·Free Radical Biology and Medicine ·(unknown), (unknown), (unknown), N Buyssens, Nancy Van Osselaer, Philippe G. Jorens, Jean Willems, Arnold G. Herman, Herman Slegers	43
14	In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (prodipine) 1997 ·Biochemical Pharmacology ·Ingrid De Meester, (unknown), Anne‐Marie Lambeir, Guido R.Y. De Meyer, Nancy Van Osselaer, Achiel Haemers, Simon Scharpé	17
15	Local Application of LDL Promotes Intimal Thickening in the Collared Carotid Artery of the Rabbit 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·K. E. Matthys, Cor E. Van Hove, Mark Kockx, Luc Andries, Nancy Van Osselaer, Arnold G. Herman, Hidde Bult	21
16	Differential effect of L‐NAME and S‐methyl‐isothiourea on leukocyte emigration in carrageenin‐soaked sponge implants in rat 1997 ·British Journal of Pharmacology ·Teresa Iuvone, Nancy Van Osselaer, Fulvio D’Acquisto, Rosa Carnuccio, Arnold G. Herman	23
17	Characterization of Synthetic Human Granulocyte Chemotactic Protein 2: Usage of Chemokine Receptors CXCR1 and CXCR2 andin VivoInflammatory Properties 1997 ·Biochemistry ·Anja Wuyts, Nancy Van Osselaer, Annemie Haelens, (unknown), Piet Herdewijn, Adit Ben‐Baruch, Joost J. Oppenheim, Paul Proost, Jo Van Damme	133
18	Relationship between interleukin-8 and neutrophil adhesion molecules in rheumatoid arthritis 1996 ·Rheumatology International ·(unknown), Luc S. De Clerck, Chris H. Bridts, Nancy Van Osselaer, W. J. Stevens	20
19	Expression of neutrophil activation markers and neutrophil adhesion to chondrocytes in rheumatoid arthritis patients: relationship with disease activity 1995 ·Research in Immunology ·Luc S. De Clerck, (unknown), Chris H. Bridts, Nancy Van Osselaer, W. J. Stevens	27
20	The neutrophil‐activating proteins interleukin 8 and β‐thromboglobulin: in vitro and in vivo comparison of NH₂‐terminally processed forms 1990 ·European Journal of Immunology ·Jo Van Damme, M Rampart, René Conings, B. Decock, Nancy Van Osselaer, Jean Willems, Alfons Billiau	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact